The push for psychedelic medicine isn't over

Also: Healey's plan for Steward hospitals; what to know about 'slapped cheek' virus [❤️ Donate]( [View in Browser]( August 20, 2024    Hi CommonHealth reader, Proponents of psychedelic medicine had a setback this month. The federal Food and Drug Administration [declined to approve]( a combination of talk therapy and MDMA, also known as ecstasy and "Molly," as a treatment for post-traumatic stress disorder. The application had been hailed as a potential milestone in the treatment of PTSD - and the broader field of psychedelic medicine. But the FDA said it needed more research.  This frustrated many patients and the drugmaker, Lykos Therapeutics, which worked with the FDA to design the trials.  "The FDA request for another study is deeply disappointing," said Amy Emerson, Lykos' chief executive, in a written statement, "not just for all those who dedicated their lives to this pioneering effort, but principally for the millions of Americans with PTSD, along with their loved ones, who have not seen any new treatment options in over two decades."  She estimated it would take several years to conduct the additional clinical trial. The FDA's response wasn't surprising. An advisory group had already given Lykos a thumbs down after [concerns were raised about its research](. Critics alleged the data failed to reflect some participants' negative experiences; a pair of therapists was removed from the trials following serious allegations of sexual misconduct. (This recently contributed to the [retractions of several research papers]( Members of the advisory panel also pointed out a more fundamental problem: Many participants who received MDMA - and their therapists - had a pretty good idea they were not part of the control group. Some had even taken MDMA before. (This was allowed in the clinical trials, but appeared to be among the concerns raised during the FDA's review.) This meant their desire to derive some benefit from the treatment may have clouded the results. In other words, it's pretty tough to blind a clinical trial when the effects of the medication under review are, well, trippy. There are [other concerns]( too, including how the government would regulate a novel combination of psychotherapy and a drug, and the way MDMA and other psychedelics can put patients in vulnerable states. Despite the decision and the concerns, many scientists in the field of psychedelic medicine expect it's a matter of [when, not if]( regulatory approvals come - for PTSD and a range of other mental health issues. Lykos' application for MDMA may yet be the first to pry open the door. Lykos is a spinoff of the Multidisciplinary Association for Psychedelic Studies, or MAPS, the driving force behind recent efforts to legalize psychedelic medicine. MAPS started with MDMA, in part, because of personal experiences described by its founder, Rick Doblin.  In a 2021 interview, Doblin told then-WBUR reporter Angus Chen that he first tried MDMA with a girlfriend when he was in his 20s. "We were able to have this discussion in a way that was really smooth and loving and open. So, that's where I felt like, 'God, I wish I could be this clear and defenseless and listening all the time,' " Doblin explained. Later, he recalled helping a friend take MDMA as she grappled with a traumatic experience. To him, it seemed like the drug helped her open up and gain confidence in her ability to move forward. "That was incredible," he said. These experiences contributed to his belief that MDMA had therapeutic potential. "You can take the lessons from the MDMA state and apply them into your daily life, and practice being that way without being on MDMA," he said. "I think that's why it's so powerful as a therapy drug." After the FDA's request for more proof that the benefits of MDMA-assisted therapy outweigh the risks, Doblin [told WBUR]( it was "one in a series of bumps in the road." "It means that we need to put out more efforts," he said. "But we will continue to do whatever is necessary because we believe that this can be a potentially very helpful addition to the treatment of PTSD." P.S.- We're watching for sales agreements for bankrupt Steward Health Care's Massachusetts hospitals. There's more on this story below and in our [politics newsletter.]( might want to [sign up]( to get future sends in your inbox!) Stay tuned to 90.9 WBUR and wbur.org for the latest. Elisabeth Harrison Managing Editor, News Content This Week's Must Reads [As Democrats meet in Chicago, Illinois' role in abortion access is in the spotlight]( As Illinois hosts the Democratic convention in Chicago, the issue of abortion - and the state's role as a hub for patients seeking the procedure - will be on display. [Read more.]( [As Democrats meet in Chicago, Illinois' role in abortion access is in the spotlight]( As Illinois hosts the Democratic convention in Chicago, the issue of abortion - and the state's role as a hub for patients seeking the procedure - will be on display. [Read more.]( [Healey: State to take control of St. Elizabeth's, tentative deals reached for other Steward hospitals]( To prevent more hospital closures, Massachusetts Gov. Maura Healey said the state will to take over bankrupt Steward Health Care's St. Elizabeth's Medical Center by eminent domain, and facilitate its transition to a new owner. She announced tentative sales for four of the company's other hospitals in the state. [Read more.]( [Healey: State to take control of St. Elizabeth's, tentative deals reached for other Steward hospitals]( To prevent more hospital closures, Massachusetts Gov. Maura Healey said the state will to take over bankrupt Steward Health Care's St. Elizabeth's Medical Center by eminent domain, and facilitate its transition to a new owner. She announced tentative sales for four of the company's other hospitals in the state. [Read more.]( [Medicare negotiated drug prices for the first time. Here's what it got]( The White House announced new Medicare drug prices for 10 medicines popular with beneficiaries. It's the first time the federal program has negotiated lower prices with the pharmaceutical industry. [Read more.]( [Medicare negotiated drug prices for the first time. Here's what it got]( The White House announced new Medicare drug prices for 10 medicines popular with beneficiaries. It's the first time the federal program has negotiated lower prices with the pharmaceutical industry. [Read more.]( [WHO declares 2024 mpox surge a 'public health emergency of international concern']( "What we're seeing is tip of the iceberg" because of weaknesses in the surveillance system, says Dr. Dimie Ogoina, chair of the WHO's emergency committee. [Read more.]( [WHO declares 2024 mpox surge a 'public health emergency of international concern']( "What we're seeing is tip of the iceberg" because of weaknesses in the surveillance system, says Dr. Dimie Ogoina, chair of the WHO's emergency committee. [Read more.]( [Massachusetts moves to phase out PFAS from firefighter gear]( Gov. Maura Healey signeda new law that will ban the sale of any firefighting jackets, pants, shoes, gloves and helmets that contain the cancer-linked chemicals, beginning in 2027. [Read more.]( [Massachusetts moves to phase out PFAS from firefighter gear]( Gov. Maura Healey signeda new law that will ban the sale of any firefighting jackets, pants, shoes, gloves and helmets that contain the cancer-linked chemicals, beginning in 2027. [Read more.]( What We're Reading 📚 - The CEO Who Made a Fortune While His Hospital Chain Collapsed ([The Wall Street Journal]( - They All Got Mysterious Brain Diseases. They're Fighting to Learn Why. ([The New York Times Magazine]( - The arrests in Matthew Perry's death expose a system built to prey on addicts ([Los Angeles Times]( Your Health [What to know about the 'slapped cheek' virus uptick in the U.S.]( Most healthy people have either no symptoms or flu-like symptoms from a parvovirus B19 infection, but it can lead to serious complications for certain groups of people. [Read more.]( [What to know about the 'slapped cheek' virus uptick in the U.S.]( Most healthy people have either no symptoms or flu-like symptoms from a parvovirus B19 infection, but it can lead to serious complications for certain groups of people. [Read more.]( 🧠💥 Did you know...💥🧠 ... scientists are studying certain bat species to understand how they metabolize lots of sugar super fast? [NPR reports]( they're hoping this research could unearth clues for treating and preventing Type 2 diabetes and obesity. 😎 Forward to a friend. They can sign up [here](. 🔎 Explore [WBUR's Field Guide]( stories, events and more. 📣 Give us your feedback: newsletters@wbur.org 📧 Get more WBUR stories sent to your inbox. [Check out all of our newsletter offerings.](   [Donate](   # # Want to change how you receive these emails? Stop getting this newsletter by [updating your preferences](.   I don't want to hear from WBUR anymore. Unsubscribe from all WBUR editorial newsletters [here](.   Interested in learning more about corporate sponsorship? [Click here](. Trustees of Boston University on behalf of WBUR, 890 Commonwealth Ave Boston, MA, 02215, US Copyright 2024 WBUR-FM, All rights reserved.